Net cash from operating activities for the three months ended Jun 30, 2019, amounted to ($31.9) million, narrower than ($96.7) million from the prior-year quarter. Guidance Revised For 2019, Avanos now projects adjusted earnings per share to range between $1.15 and $1.25 compared to the prior guided range of $1.15-$1.35. Avanos anticipates 2019 net revenues to increase 8-10% year over year (up from the previously guided estimate of 6-8%), on a constant-currency basis (including Game Ready and now NeoMed). Notably, the other key planning assumptions that management provided in the 2018 conference call remain unchanged.